C-ATJCRegerna Therapeutics
RNA-binding proteins, AUF1, muscle regeneration
repairinggene therapy
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-ATJC
C-ATJCC-ATJCRNA-binding proteins, AUF1, muscle regeneration
0-100 chain-logic scale · 15 dimensions · scored on public evidence
VentureRadar 0){if($('#i_b_toggleMore').hasClass('active')){Search_Elastic();}else{Search_DeconstructSearchString();Search_Elastic(false);event.preventDefault();}}else{event.preventDefault();}}" onclick="this.removeAttribute('readonly');" ontouchstart="this.removeAttribute('readonly');" id="i_t_Search" name="VRSearch" readonly> All Ranked Organisation Names Apps and Links Homepage (myVR) Funding Deals Hub Similar Companies App Articles Manage Account Logout Login Free Sign-up You must have cookies enabled to login Refresh (When Cookies Enabled) Forgotten your password? By continuing, yo … s of Service , Privacy Policy and Cookie Policy . View More With A Free Account Submit or Claim Your Company Register for Free How to Increase your Company's exposure OR Create an Account for More Register for Free View Pricing for full Business Subscription OR More about VentureRadar VentureRadar Database VentureRadar Services VentureRadar for Companies Terms & Conditions Privacy Policy Cookie Policy Copyright ©2024 VentureRadar. All Rights Reserved. Upgrade to a Paid P … nditions Privacy Policy Cookie Policy Contact Us Twitter LinkedIn | Submit a Company Directory of Companies Free Sign-up for VentureRadar access You must have cookies enabled to create an account with VentureRadar Refresh (When Cookies Enabled) Return to home page Login Free Sign-up for VentureRadar access or By continuing, you agree to VentureRadar's Terms of Service , Privacy Policy and Cookie Policy . Create a Free Account to Follow Companies To continue, pleas
VentureRadar 0){if($('#i_b_toggleMore').hasClass('active')){Search_Elastic();}else{Search_DeconstructSearchString();Search_Elastic(false);event.preventDefault();}}else{event.preventDefault();}}" onclick="this.removeAttribute('readonly');" ontouchstart="this.removeAttribute('readonly');" id="i_t_Search" name="VRSearch" readonly> All Ranked Organisation Names Apps and Links Homepage (myVR) Funding Deals Hub Similar Companies App Articles Manage Account Logout Login Free Sign-up You must have cookies enabled to login Refresh (When Cookies Enabled) Forgotten your password? By continuing, yo … s of Service , Privacy Policy and Cookie Policy . View More With A Free Account Submit or Claim Your Company Register for Free How to Increase your Company's exposure OR Create an Account for More Register for Free View Pricing for full Business Subscription OR More about VentureRadar VentureRadar Database VentureRadar Services VentureRadar for Companies Terms & Conditions Privacy Policy Cookie Policy Copyright ©2024 VentureRadar. All Rights Reserved. Upgrade to a Paid P … nditions Privacy Policy Cookie Policy Contact Us Twitter LinkedIn | Submit a Company Directory of Companies Free Sign-up for VentureRadar access You must have cookies enabled to create an account with VentureRadar Refresh (When Cookies Enabled) Return to home page Login Free Sign-up for VentureRadar access or By continuing, you agree to VentureRadar's Terms of Service , Privacy Policy and Cookie Policy . Create a Free Account to Follow Companies To continue, pleas
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Transforming Lives in the Lake Basin Region through Sustainable Water Solutions. | Lake Basin Development Authority
The Muscle Tissue Environment Limits Muscle Stem Cells in Aged Mice | bioRxiv Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results The Muscle Tissue Environment Limits Muscle Stem Cells in Aged Mice View ORCID Profile Alicia A. Cutler , View ORCID Profile Tenaya K. Vallery , View ORCID Profile Thomas O. Vogler , View ORCID Profile Jesse Kurland , View ORCID Profile Thea S. Zlatklov , Tiffany Antwine , View ORCID Profile Nicole Dalla Betta , View ORCID Profile Tze-Ling Chang , View ORCID Profile Brad Pawlikowski , Carson H. Butcher , View ORCID … om the ALSAM Foundation (BBO), NIH AR049446 (BBO), NIH AR070630 (BBO), AFAR BIG Award (BBO), and NIH DK120921 (KSA). Author Contributions AAC, TKV, TOV, TLC, KSA, and BBO conceived the experiments. AAC, TKV, TOV, TSZ, NDB, TA, TLC, BP, and CHB performed the experiments, analyzed data, and made Figures. KJL and DMO developed and characterized the caFGFR1 transgenic mice. JK, TSZ, and TKV performed bioinformatic analysis of single cell sequencing. AAC, TKV, and BBO wrote the ma
NEWS – LIPID SYSTEMS – liposome technologies Company About Team EU Projects Technology Pipeline NEWS Contact na dla hamburgera i dodanie aria-label. (Możesz zostawić lub , ale wtedy musisz dodać role="button" i tabindex="0", dlatego jest tu optymalny) --> NEWS Supportive Care solutions presented on Vita Foods 2024 in Geneva by Lipid Systems ! 2024-05-17 Read More : Supportive Care solutions presented on Vita Foods 2024 in Geneva by Lipid Systems ! New distribution agreement signed. 2023-11-30 Lipid Systems has acquired a new Partner for distribution in Israel. Welcome on board … e : 11-19.10.2023 – CPHI related B2B meetings in Wrocław EPO Intention to grant a patent protection to LipoShell® technology. 2023-10-12 European Patent Office after extensive examination of LipoShell® patent application has issued intention to grant a patent protection under Rule 71(3) EPC. Read More : EPO Intention to grant a patent protection to LipoShell® technology. Grant of patent protection for LipoShell® technology in AU 2023-10-12 Read More : Grant of … -12 Read More : Grant of patent protection for LipoShell® technology in AU Grant of patent protection for LipoShell® technology in the US 2023-09-19 Read More : Grant of patent protection for LipoShell® technology in the US Vitafoods Europe – Thank you. 2023-05-12 It was a busy 3 days at Vitafoods Europe! Thank you for all your interest and inspiring meetings. Liposomes are one of the fastest growing technologies in nutraceuticals now. It’s good to be a part of it!&
Axelle Bois posted on LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , and Cookie Policy . S
#mrna #partnerships #research #vaccine #therapeutic #oncology #cancer #kidney #lnp #nanoparticle #nanomedicine #mrnavaccine | Huzefa Rupawala, Ph.D. LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By … rethink for Crohn’s disease is taking shape. Trethera just received a $1.8M NIH grant (on top of a prior $400K) to advance TRE-515, a once-daily oral deoxycytidine kinase (dCK) inhibitor, toward IND-enabling studies in Crohn’s disease. The molecule, originally developed in oncology and ALS, has shown head-to-head preclinical efficacy exceeding ustekinumab in mouse models by selectively limiting activated CD4 T-cell proliferation — pointing to a potentially new, more targeted … nsDisease #ClinicalTrials #Immunology #BiotechInnovation Trethera Awarded $1.8M Grant for Crohn’s Drug Development https://www.clinicaltrialvanguard.com 1 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Luke Woods 8mo Report this post 𝐁𝐢𝐠 𝐧𝐞𝐰𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐦𝐑𝐍𝐀 𝐚𝐧𝐝 𝐜𝐞𝐥𝐥 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐬𝐩𝐚𝐜𝐞! The U.S. Department of Health and Human Services (HHS) has just awarded $48 million to Kernal Biologics to advance their mRNA-encoded
"muscle wasting" | VentureRadar search 0){if($('#i_b_toggleMore').hasClass('active')){Search_Elastic();}else{Search_DeconstructSearchString();Search_Elastic(false);event.preventDefault();}}else{event.preventDefault();}}" onclick="this.removeAttribute('readonly');" ontouchstart="this.removeAttribute('readonly');" id="i_t_Search" name="VRSearch" readonly> All Ranked Organisation Names Apps and Links Homepage (myVR) Funding Deals Hub Similar Companies App Articles Manage Account Logout Login Free Sign-up All these words: Type the important words Any of these words: Type the words you want … None of these words: Type the words you don't want Data set filters: Government Grant Incubator / Accelerator Backed Spin Off Venture Funded Select required data sets Country: Any Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia … nalysts do the work for you with VentureRadar Services . Want to add a company? Submit a Company . Company Country Status Score {cn} {cc} {cs} {gsg} Preview Upgrade now to view more search results Upgrade Now Upgrade now to view beyond page 1 of search results Access Full Search Results with a Business Account or On Demand Pass Upgrade Now Free limit reached n/a Private 100 Upgrade Upgrade for full access n/a Upgrade 35 Upgrade … {sls} Source: {s}{sle} {cn} {ct} {cf} {cc} {cd} GOVERNMENT GRANT SPIN-OFF INCUBATOR BACKED VENTURE FUNDED EQUITY CROWDFUNDED REWARD CROWDFUNDED GOVERNMENT GRANT SPIN-OFF INCUBATOR BACKED VENTURE FUNDED EQUITY CROWDFUNDED REWARD CROWDFUNDED {cw} {t} {sn} Source: {s} RANKED RESULTS NAME MATCH RESULTS {CompanyDescription} {CompanyDescription} Upgrade now to view more search results Access … nditions Privacy Policy Cookie Policy Contact Us Twitter LinkedIn | Submit a Company Directory of Companies Login Free Sign-up for VentureRadar access or By continuing, you agree to VentureRadar's Terms of Service , Privacy Policy and Cookie Policy . Free Sign-up for VentureRadar access You must have cookies enabled to create an accou
Nonreplicating synthetic mRNA vaccines: A journey through the European (Journal of Immunology) history Nonreplicating synthetic mRNA vaccines: A journey through the European (Journal of Immunology) history Eur J Immunol . 2023 Jul;53(7):e2249941. doi: 10.1002/eji.202249941. Epub 2023 Apr 24. Author Steve Pascolo 1 2 Affiliations 1 Department of Dermatology, University Hospital Zürich (USZ), University of Zürich (UZH), Zürich, Switzerland. 2 Faculty of Medicine, University of Zürich, Zürich, Switzerland. PMID: 37029096 DOI: 10.1002/eji.202249941 Abstract The first worldwide articl
New 2025 BIO Members | BIO Skip to main content --> Policy Get Involved Join BIOAction View Advocacy Toolkit Patient Advocacy Human Health Cost and Value of Biopharmaceuticals Antimicrobial Resistance Vaccines & Biodefense Drug Development & Review International Global Markets & Trade Multilateral Organizations Intellectual Property Science & Regulatory All Policy Patient Advocacy Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access. Member Membership Options Become a BIO Membe
USA Life Sciences Database This website uses own and third-party cookies to enhance the user's experience. By clicking "Accept" on this banner or using our site, you consent to the use of cookies. For settings and more information about cookies, view our Terms and Cookie Policy . Accept Database Life Science Map Statistics Industry sectors Biotech Medtech Digital Health Swiss Life Science Trend Analysis News & Events News Events About Us Who we are Our partners Add / update company Contact Global Database Global Database Global Trial Global Log-in --> Regerna Therapeutics Regerna The
Medway and surrounding areas Small business and handmade items | Small Independent Business that is a one stop shop for all your wheel and tyre needs NOT just a refurbishment company.
%PDF-1.7 %���� 1 0 obj > endobj 2 0 obj > endobj 3 0 obj >/Font >/XObject >/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 960 540] /Contents 4 0 R/Group >/Tabs/S>> endobj 4 0 obj > stream x��U�N1}_i�a�*/"��R��R�B�>T}�梒,l6 �G����&H���'��̙c�&�.��J� �T�5�2�~��,�N.,���� ��7/rZ��z����> ��ѷ8��H�F bM�],Ӗ� �@wG 8S.S�X��SJ�� �jU�jp�` � �N����`��O�K���� ,(A�q ���枿`�0�Z0��)�d�O �k� ��L ���Q}d��3�J|V>V�3[ax^� _m0�r�l�Vz�)�5�[>�ep�f5� ���� endstream endobj 5 0 obj > endobj 6 0 obj > endobj 7 0 obj > endobj 8 0 obj > endobj 9 0 obj > endobj 10 0 obj > endobj 11 0 ob … �2B� b�K�|��N#�O]�r �v�*��� {����v ��v���1zF��_���ٮ�s9W_-|�L����x �Ic#��RFP:�HT�p�� }�j=�+�u Ed=����8 �=4�DTQ*���bH�NH�2�ٯg������䈰ġ��9B8+�z�T`��D� ���i$�K2��K��\�'�µ�v� ��QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE �Q@ �֣��kW :���b(?x6 ��j�~�G���o%WlIn\H�Ca�t늺� Y�=B�칊y��4��u� � ���:=�����c`a����H]j2O� �����Β�����X_$H�2e^p>�+y��:��˽�� �,�cв�&�mɦ���-��P��H���x �P … hӸ]�>c�ڲ�4����>���ە��9H.�GP �� �ʜ��7N�����4y���t���3H �4MB���hV�ZwU�Y3�+ �rFp ��s��n�"�ɻ��ȸS�W̍�)���*���v������{�� ��������{�� P�� � "�EPYs���OJ�h����.�-BXu 5�B+:^P`_��:�p@�G��O�jSE�Z =��4wfD� *w� u*F�s�s� x�]�� ���檗��;Ɨ�t%����388#8���i��xv��{t��)�@�$��#�mQIh�Wq�R�D ���G��Ve���'���i�L}��Te I8��kQI�� ���+�G��j�,��� �*�H$�G$v�kV�O�-/�K�3NY � �7��8$tWYESw����G!�蓭���� k8�Y �*�z��,Z=�H�2�� *GB+F�w��q�'�5MKT3E�#T6m�(H\ �����5vc��� ��I6�"�` … x���Ak1����9&�q&�dw��UZ��v��҃h�.�n�m�����(hA(� f^�7o�� "�֘B�l���=�`��`�d��rFP���{�^�8{�l 4������U\GHC����rJUJ�Q��AQGX�0��E�7�d"2� � g7�)�ъ�u�Ēr�`�X�g�����,0�����j�a�2���Lƪ�hH�LŴ?��Q��פ���� ��Z��9 �'Ʌ��������A�Y�PZ�է�T�$�x���7M)�=�k?��u��-� �L�o^���>���� Y�� endstream endobj 2521 0 obj > stream ����JFIFHH��:ExifMM*QQ Q ��C !( !0*21/*.-4;[email protected]?]c\RbKSTQ��C''Q6.6QQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ
%PDF-1.3 %��������� 3 0 obj > stream x���N�0 E�����E3v^�� > endobj 4 0 obj > /Font > /XObject > >> endobj 8 0 obj > stream x���丑.����f��hFյo�K2��q|AO$�`FfU���2��@��; F���~~����~�)�� ~�˫��3�__�y�Ï=47�|�� �}�Ϟ�����|�ͫ �Ѵ?����?���7o���_߾��7��������e HD�����5Ae��#&��}� ���{�!ȷ��H����?�x� �����#n���B �~���_^�B������a�(*?����_��_��� ��W�~Gj�~������3�ܦ���} ��_�Dt�������FK~�R��}���p��������ۅaC��/������7��=��7o`��7x���w���� ����J >�#�ׯq�������5�h���IgA�MEp��D�(������Ei&�~�[Pχ���jS�F`����ƫ��2(���˗q����T�%&;d�1̍8�ܓ����#qJ؝��893qr1K�� �D�h5w��o��/>|,��m���������? … &�q�L�C͘��4�Kv) �����{��.����\P�I_+�@��uw�S��4gL��h��b !Zvp%c��Y��� )��ӣ�rFp�Q���r�� 4h�t�c_ ������$�Wk������������ǦVB 'd�P&gWO�Y�-�s�P�41s rL� ���,X���(���_Ę���{sja^��N*m�y�??+;Գr��$�B��(�[V2k1�� .�^N �4���,)= �u� q�6G1��{�b~.�|�}G���[�#�'�\��q��[74�A��I�#���q]sצ�綝�� G�Ƙ�1�"��a��{4d�d��~�ZG�@'k�����q�c�-��H":�{��2$�>KG����2R�$�d���� ���sw��s�������x���*� �d{sվS�>��������o�|������"$��j9��G�?҂ҀD Jo���ƠU32�k(���^�)�dÄ��O� [>��?�A
%PDF-1.6 %���� 1 0 obj > endobj 2 0 obj /Company /CreationDate /Creator /ModDate /Producer /SourceModified >> endobj 3 0 obj > stream ��/��ՙ�,�@ 2�|�������GJ����}�ܭ 7{R�^"!���Ո~��� C�;�3� iu9�����C����[5D�P"���[�M� ��F� ����i_V�w��0���q%����BtS �b!$��ఏ�~5M1�]P���3�v�O�k��e��7^͔�P�R����ΑaI�s C�c�i7 !�O(��F_GXFH��&�~��:f�^߀E�W~|07?x� ��7�i���}��N�E���Q��`�QM��w��H6� K��C���%İ�� �D�Y@�>P�'ֶ�Lh���� �M0 EX��{��$�P/i��m��� N� ���;7� -=��Mne�DB .�5�*C\9tu/�VKf��Ld�d�:J2}�S��R��,?.��,��.��3"�bK� /6�0~��"�� > endobj 5 0 obj > endobj 6 0 obj >> endobj 7
%PDF-1.7 %���� 1 0 obj > endobj 2 0 obj > endobj 3 0 obj >/XObject >/Font >/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 960 540] /Contents 4 0 R/Group >/Tabs/S>> endobj 4 0 obj > stream x��V�n�0 }7���`�*ɒe?v�!ݺ[S��C�8��\Z�ِ���r�d��4 Pd(b�4�sER~�=�q΅��@�pЊCU��0���� ù� ��y"x���o}��=���*�Tƒ̅Ug�F`�џ�131��7� hg� ��`7&��..� $tĕ" ȔdB���i � ZM�������~���w[ ѿ�"� �b�Q��q4�A�$f�4g:�,e�� ��#A*ƥ��$3(S���F���'�j1^B��UK�#��%�¼����d�Yj^�AƷ%�)�%�s�llK�@�� xŁ}�taJ��:7?#)� �A����?��tC_̦h�P�SEƕ=L1@�.���n��#m_��.xA��}a��It���BepCq�-_T�IuY�Y0G�´X���,o�u�}���^m … EQEQEQEQEQEQEQEQEQEQEQEQEQEQE�x#�FO����%vu�x#�FO����%v/9R�T�RFp}E:�( �[�~���z � ޣ��y����� ��Xc�S�t@Ϲ jz(����t���y I,��G��� h�%�]F�n�ź6���g�p=� �W��5��-���k6���v�`=��uQEQEQEQEQEQEQEQEQEQEs�?�K����1k��w���w����F-tTQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEW��� bÿ�Q ����6袊(��(��(��(��(��(��(�L�\/' *����떿o-�����M:2FԵ���@3�?J�(�WI��2"��k�B�l�'�0J�����U@Q@ ��������Z諝���"]����ы]W+�5�� ?� �AEPEPEPEP … �� �a�{T��O"��� 6��]I����?�58��$�j�3.�:_�^�ϐ���U^{Id�GVR � ����@"�#����L��rFp*[� �2���`*�;�\��F*[�2��I�Rn�Oq�r� ��x@�Tx$��)'fH9� ��vlˀ�3�Č�c��2G1��� � ��+�rL�G�� "�c�vǸ �AqsH-�`��GB��GE��ՙH!Gn;��L Ջwܒ��KR,�3;u� * �\��0h��Y@'#��Һ�y�9�1�s��q�{VZ�[�9�1r� �Q�&4\�1�$��A~��u,�kv������� �������d 2H sO��5+���R����G� ���;Zb����&�`m�>�S#�A,���RP��A=3�GN��V��1��Q"��B����Y��L1C+ŸJ�#�-�1 a9� 8�3��: �Z�hR�j$�٢F c$ �j[�Skh�I���)�ZK{�m��F�DҲ� … �u�-��g=��"�C�-�s�3^�Y��ZLZ�ԣ��[�I�Bs���}����N�k��jֳ��5�(�n�f� ��彍%� I9(�>RFp~�أU�a���\��w=��K���\g�jO � ���u=M��*T�rI?Ҁ Sϵv����ׄ� ?\�h-. Zo�ЎKzs����>����R�O������+�A�?�z�e�_� +YZKs�\D���N5��R�A�U�I��K�=A��Ε�q��;@��Ezދ��zRG�ڬ"B ��f�L��s@ �]�����W_m��ۍ�*dž��O*3�w�j� K�֍s��\ �Y�ȶ��,sϮ3^K}gs��Iiy C X!{g��@ ��/ [���x�R�1�hҬL�B���1�ⶵO�MƗw�z�� �푌�g�+����u�������!�F����,v��X�H#�Ew NJ�R�o/ne�� �,���@��2}� ��� J��'� ��k�;�Kveѧ�i�gʧuV��k�(���E
Maidstone & Kent Business Community Group | Small Independent Business that is a one stop shop for all your wheel and tyre needs NOT just a refurbishment company.
Sittingbourne and Surrounding areas, Business Advertising Group. | Small Independent Business that is a one stop shop for all your wheel and tyre needs NOT just a refurbishment company.
Montanara Skip to content Home Speakers Pages About us Become a sponsor Exhibitors Gallery Partners Register Schedule Tickets Venue Blog Contact Buy ticket The best industry conference Don't forget to write some bold copy to show what really matters See more Buy ticket Some cool stats Nothing sells quite as well as a good statistic. That, plus awesome speakers, exhibitors and world-class content. 25 Speakers We have many experts 300 Registrants Available for everyone 35 Live workshops Before and After event Our top line-up There's only one place where you can get to connect with this group of … ing RNA Therapeutics Development: Novel Reagents for DNA Template Production by Rolling Circle Amplification The rolling circle amplification (RCA) is an isothermal amplification technique that shows promise for generating DNA template for in vitro transcription (IVT) reaction used in therapeutic RNA production. Compared to using bacterial plasmids as DNA templates, RCA offers several advantages as speed, simplicity and safety For mRNA therapeutics development the AOF (animal
Inserm Transfert Chercheurs Protéger mes résultats Développer mon projet (recherche, innovation) Impliquer des industriels Maturation-Prématuration de France2030 Le consortium CATRIEM Le consortium COMBIO Le consortium COMS@N Réfléchir à l’entrepreneuriat Parcours Pré-Entrepreneurial Rencontres du parcours Pré-Entrepreneurial Human Health Startup Factory Industriels Une offre d'exception Une réponse dédiée à votre besoin Nos domaines stratégiques d'innovation Investisseurs Inserm Transfert Notre mission & nos succès Notre gouvernance Notre histoire Notre politique qualité Carrières Technology … opper un système de stratification des risques en transplantation rénale en intégrant des données multidimensionnelles issues du suivi des patients. ... CARE IMI Le consortium CARE est une coalition de 37 institutions académiques, industries pharmaceutiques et organismes de recherche à but non lucratif dont les principaux objectifs sont le développement de ... TheraLymph H2020 Le lymphœdème est une maladie invalidante, où des liquides s’accumulent dans un tissu de manière loc
See Who Attended in 2024 | BioFuture BioFuture Partnering Registration ABOUT About BioFuture News and Resources 2025 Photo Gallery Contact Us AGENDA Speakers 2026 Agenda 2025 Agenda Biofuture Past Agendas Committees ATTENDEES Why Attend? 2025 Attendees 2024 Attendees List of 2025 Registered Investors Social Media Tools PRESENT ON SPOTLIGHT OR SEED PANEL Apply to Present on a Spotlight Panel Apply to Present in the Seed Showcase List of 2025 Presenting Companies Panel Presenter Guidelines PARTNERING MEETINGS SPONSOR REGISTRATION VENUE See Who Attended in 2024 Register 64x Bio 7G BioVentures A C … Foundation Cathay Capital CCRM Enterprises Cellino Chimeron Bio Chugai Venture Fund, LLC City of Westerville Cohesion Bureau Connecticut Innovations CR Ventures (Clinical Research Ventures) CVS Health – Caremark Division Cytonus Therapeutics Daiichi Sankyo, Inc. Danforth Advisors Dantech Corporation Inc. Deal Partners Group DeepCure DepYmed, Inc.Digital Health New York Digital Networks PLC DLA Piper Eagle Asset Management Inc East Egg Project Management EisnerAmper LLP … nology News Georgia Bio Glucotrack Inc Golden Seeds Good Health Capital HatcBio Fund Healthline Helex Hervolution Therapeutics High Cape Capital HM Venture Partners Hogan Lovells US LLP Horizon Technology Finance Iaso Biotherapeutics iBio, Inc. IBM Ideal Medical Technologies Inc. Immunis Inc. IN8bio Indaptus Therapeutics Initiate Ventures & Studio Invenis Biotherapies IPF Partners Ipsen Ipsos JJDC JLS Fund Joseph Ventures JPMorgan JT Pharma Just Evotec Biologics Kaida Bi … gement MSKCC Museum of Medicine and Biomedical Discovery MVM Myeloma Investment Fund Myria Biosciences NCBiotech Neuroelectrics Barcelona SLU Neuronoff, Inc. Neuvation Ventures, LLC New Enterprise Associates (NEA) New York Angels NewYorkBIO Noctrix Health Nodenza Venture Partners Nostopharma NovaQuest NSIP LLC NUP-CTx Inc. Nusano NuvOx Pharma, LLC OncoRx Insights, Inc. Ontario Trade & Investment Office, NY Optic Inc Orange Grove Bio Origami Therapeutics, Inc. Orrick, Her … P4CI Partnering for Cancer Innovation Pacific 8 Ventures Panacea Venture Pangen Fund I GP LLC Pappas Capital Perceptive Advisors Pfizer Pictura Bio Ltd Playground Global Pliancy Polaris Quantum Biotech, LTD Portrai PredxBio Prevail Partners LLC. QPMind Quantum Media Group R/Evolution Gate Ray Therapeutics ReadHealthy Communications Regeneron Phar
The expanding world of RBPs: from posttranscriptional control to riboregulation – Course and Conference Office European Molecular Biology Laboratory Home Directory Search Edit EMBL Conference The expanding world of RBPs: from posttranscriptional control to riboregulation Overview Speakers Programme Practical Information Sponsors Media kit Airport strike information Overview This conference will take place at EMBL Heidelberg, with the option to attend virtually. Conference overview Based on recent methodological breakthroughs, the number of identified mammalian RNA-binding proteins (RBPs) … include access to all of the talks (livestreamed and on demand) and facility to submit questions. On-site Academia €800 On-site PhD Student €700 On-site Industry €1000 On-site Journal Editors * €300 Virtual Academia €225 Virtual PhD Student €175 Virtual Industry €275 * Editors from scientific journals are allowed to attend at a reduced rate, but asked to contribute to the conference in return by taking part in ‘meet the editors’ sessions or other planned activities within the … r other planned activities within the programme . A letter to support your visa application will be issued, on request, once payment of the registration fee is confirmed. We recommend that you book your visa appointment as soon as possible, to avoid any delay with your visa application. Accredited journalists may be eligible to register for complimentary press registration. Registrants may be required to provide accreditation or equivalent proof of press membership after regi … ssion Only participants registering to attend the on-site event are eligible to submit an abstract. Abstracts will not be accepted from virtual participants. After registration you can submit your abstract via a separate link that will be provided in the email confirmation. Alternatively, you can access the link on the confirmation page directly after registering. The same login credentials are used for both processes. Please note: Abstract body: The limit of 2000 characters … n the abstract book. Presentation types: When submitting your abstract, you can apply for an oral or poster presentation. A selection process will take place with the results announced 2-3 weeks after the abstract submission deadline. For detailed instructions on how to submit a conference abstract, follow the instructions provided in this video
2025 Breast Cancer Symposium Home Page | Stony Brook Cancer Center Skip to main content Contact Us Find a Provider Pay Doctor Bill Give Home Why Choose Us? Message from Leadership New Director Appointed About Us Our Mission Cancer Center Leadership Cancer Care Teams Outpatient Cancer Center and Research Facility Overview Leadership FAQs Fact Sheet Make A Gift Awards & Accreditations Patients Cancer Care Teams Diagnosis & Treatment Second Opinion Program Cancer Clinical Trials Community Outreach and Engagement Find A Cancer Provider Cancer Genetic Counseling Meet Our Docto … his achievements, including the 2019 American Cancer Society Cancer Researcher award. He is also a co-founding scientist of seven biotechnology/small companies, including ImClone Systems (New York), PTC Therapeutics. (New Jersey), and most recently, Regerna Therapeutics. Registration Deadline: September 19, 2025 CALL FOR ABSTRACTS and POSTERS Submit an abstract for the Symposium eBook celebrating research, new discoveries, and achievements in medicine and scien … g research, new discoveries, and achievements in medicine and science. You must submit an abstract to submit a poster. We encourage undergraduate and graduate students, postdoctoral associates, research specialists, and research scientists/assistant professors to submit an abstract and poster. Original research, case reports, and case series are welcome. eBook Abstract Submission Deadline: Sept. 8, 2025 Poster Submission: September 26, 2025
Regerna Therapeutics | Advance Muscle Treatment Today 0 Skip to Content About Science Pipeline Team Publications Contact Open Menu Close Menu About Science Pipeline Team Publications Contact Open Menu Close Menu About Science Pipeline Team Publications Contact Unlocking muscle biology with innovative medicines Restoring Functional and Endurant Muscle for Healthy Aging, Longevity and Muscle Injury and Wasting Diseases. Learn more First-in-class mRNA Binding Protein Therapeutics. First-in-class mRNA Binding Protein Therapeutics. First-in-class mRNA Binding Protein Therapeutics. Restoring muscle, … ein therapeutics, for which received 2025 BioInnovation Institute & Science Prize for Innovation Highly experienced investigator in muscle biology 12 years+ in muscle regenerative medicine and muscle aging process Co-inventor on all Regerna IP PhD in Biology, Health and Biotechnology from the Toulouse University LinkedIn Manisha Narasimhan, PhD SENIOR ADVISOR Chief Corporate Development and Digital Officer, Bausch + Lomb Former CFO & co-founder, Vesper Healthcare. For … , PhD, Regerna CSO, Wins Finalist in 2025 BioInnovation Institute & Science Prize for Innovation July 2025 Read More Interview with Dounia Abbadi. Dounia has spent her career investigating a part of the body we use every single day: our muscles. April 2025 Read More mRNA binding proteins join the longevity pipeline: Rebuilding muscle through the power of mRNA binding protein therapeutics April 2025 Read More AUF1 gene transfer increases exercise performance and improves s … re about Regerna, or to receive a copy of our Introductory Presentation, kindly submit an inquiry through this page. Interested in investing? Submit an inquiry on this page to receive our Investor Deck.
--> MIT CEO | Longwood Healthcare Leaders top of page - About Upcoming Meetings Past Events Gallery Sponsors Giving Back REGISTER Featured Speakers Highlights Venue Agenda Speaking Faculty Accommodations Supporters Upcoming Meetings Boston CEO: November 2-3 Featured Speakers Agenda Register San Francisco CEO: January 9-10 Featured Speakers Agenda Register Miami CEO: March 10-12 Featured Speakers Agenda Register MIT CEO: June 14-15 Featured Speakers Agenda Register MIT CEO June 14-15, 2027 Koch Institute at MIT In order to further cultivate biomedical innovation and the advancement of medicines … Heiden Executive Director Koch Institute at MIT Christoph Westphal GP, Longwood Fund; Founder/CEO, Alnylam/Momenta 2026 Featured Speakers Leading BioPharma CEOs Grace Colón CEO OmniPulse Biosciences Jeff Leiden Executive Chair Vertex Brett Monia CEO Ionis Marc Tessier-Lavigne CEO Xaira Chris Viehbacher CEO Biogen Renowned Academics & Leading Researchers Lotte Bjerre Knudsen Lasker Award Winner GLP1 Atul Gawande Former Assistant Administrator, Global Health USAID (2022 – 2 … ation & Networking Breakfast 7:40 am | Biotech Update & Longwood Fund Introduction Christoph Westphal , General Partner, Longwood Fund 8:00 am | BioPharma Pipeline Sourcing Uli Brödl , Head, R&D & CSO, Grünenthal Jenny Laird , Global Head, BD, Neuroscience, Eli Lilly & Company Michal Preminger , CEO, BioMed X Venture Labs Morten Sogaard , SVP, Innovation Lab, Astellas Moderator: Sekhar Naik , CEO, MResult 8:30 am | Driving Produc … tors: Sekhar Naik , CEO, MResult Christoph Westphal , General Partner, Longwood Fund 10:00 am | Networking Break 10:30 am | Aligning Priorities with the Board Meeta Chatterjee , Former Chief Strategy Officer, Sun Pharma Mahesh Karande , CEO, Stealth Bio David Khougazian , Chairman, Montai Paul Sekhri , CEO, vTv Therapeutics Moderator: Jason Cole , CEO, Zag Bio 11:00 am | Maintaining Patient-Centric Focus Jessica Grossman , CEO, IgGenix Alessandro Maselli , CE … Moderator: Christoph Westphal , Founder/CEO, Momenta; General Partner, Longwood Fund 4:25 pm | Assessing Investment Risk Anna French , Managing Partner, Qiming Venture Partners US Omar Khalil , Managing Director, Sante Ventures Kush Parmar , Managing Partner, 5AM Ventures Geeta Vemuri , Managing Partner, Agent Capital Moderator: Sean O&rsq
AUF1 gene therapy for traumatic skeletal muscle injury: significantly accelerated muscle regeneration in preclinical models - MDA Clinical & Scientific Conference 2026 and tags on every page of your site. --> Register Now --> Home MDA Conference 2026 Registration Rates Agenda Location & Venue Our Sponsors CE Media Information Sponsorships & Exhibits Sponsorship Levels Event Sponsorships Marketing Sponsorships Exhibit Information Patient Advocacy Pavilion Abstracts 2026 Abstract Guidelines 2026 Abstract Library 2025 Abstract Library 2024 Abstract Library 2023 Abstract Library 2026 … Demand Conference About Us About The MDA Conference About MDA Awards MDA Legacy Award for Achievement in Clinical Research The MDA Donavon Decker Community Impact in Research Award MDA Research Momentum Award Future Conferences Contact Us Home MDA Conference 2026 Registration Rates Agenda Location & Venue Our Sponsors CE Media Information Sponsorships & Exhibits Sponsorship Levels Event Sponsorships Marketing Sponsorships Exhibit Information Patient Advocacy Pavilio … Demand Conference About Us About The MDA Conference About MDA Awards MDA Legacy Award for Achievement in Clinical Research The MDA Donavon Decker Community Impact in Research Award MDA Research Momentum Award Future Conferences Contact Us AUF1 gene therapy for traumatic skeletal muscle injury: significantly accelerated muscle regeneration in preclinical models Topic: Translational Research Poster Number: S23 Author(s): Robert Schneider, PhD, Regerna Therapeutics, NYU Grossman
mRNA binding proteins join the longevity pipeline: Rebuilding muscle through the power of mRNA binding protein therapeutics mRNA binding proteins join the longevity pipeline: Rebuilding muscle through the power of mRNA binding protein therapeutics Science . 2025 Apr 4;388(6742):41. doi: 10.1126/science.adw0395. Epub 2025 Apr 3. Author Dounia Abbadi 1 2 Affiliations 1 New York University Grossman School of Medicine, New York, NY, USA. 2 Regerna Therapeutics, New York, NY, USA. PMID: 40179168 DOI: 10.1126/science.adw0395 Abstract Rebuilding muscle through the power of mRNA binding
Regerna Therapeutics - BIO International Convention 2026 Start your engines! BIO 2026 is June 22-25 at the San Diego Convention Center. Program announced! See the 130+ sessions in 18 focus areas. Generate Your Personal Event Schedule in Seconds! GENERATE NOW Start your engines! BIO 2026 is June 22-25 at the San Diego Convention Center. Program announced! See the 130+ sessions in 18 focus areas. Generate Your Personal Event Schedule in Seconds! GENERATE NOW June 22-25 | San Diego Event Info Event Overview About BIO International Convention Future dates Attendee Policies Schedule at a Gla … ific Progress AI Implementation Biomanufacturing Academia Company Presentations Apply for a Company Presentation 2026 Presenting Companies Curated Programs AI Summit BIO Storytelling Stage BioProcess Theater Global Innovation Hubs Professional Development Courses Start-Up Stadium Student Program BIO Partnering™ BIO Partnering™ at BIO 2026 BIO Partnering™ Overview Pre-Event Webinars Partnering Resources LOG IN TO BIO PARTNERING Participating Companies All Partnering Companies … Amgen Genentech Boehringer Ingelheim Lilly Novo Nordisk Sanofi Academic Campus Apply for Academic Campus Exhibition Directory and Map Event Directory Exhibitor List Exhibitor In-Booth Events Event Map Exhibition Hours Exhibition Reception BIO Booths BIO Business Solutions® Pavilion BIO Member Lounge Networking BIO Receptions Other Events Social Spotlight Events Affiliate Events Application Special Experiences 5K and 1 Mile Course BIO Gives Back Headshot Lounge Matchday Loung
Regerna Therapeutics | Advance Muscle Treatment Today 0 Skip to Content About Science Pipeline Team Publications Contact Open Menu Close Menu About Science Pipeline Team Publications Contact Open Menu Close Menu About Science Pipeline Team Publications Contact Unlocking muscle biology with innovative medicines Restoring Functional and Endurant Muscle for Healthy Aging, Longevity and Muscle Injury and Wasting Diseases. Learn more First-in-class mRNA Binding Protein Therapeutics. First-in-class mRNA Binding Protein Therapeutics. First-in-class mRNA Binding Protein Therapeutics. Restoring muscle, … ein therapeutics, for which received 2025 BioInnovation Institute & Science Prize for Innovation Highly experienced investigator in muscle biology 12 years+ in muscle regenerative medicine and muscle aging process Co-inventor on all Regerna IP PhD in Biology, Health and Biotechnology from the Toulouse University LinkedIn Manisha Narasimhan, PhD SENIOR ADVISOR Chief Corporate Development and Digital Officer, Bausch + Lomb Former CFO & co-founder, Vesper Healthcare. For … , PhD, Regerna CSO, Wins Finalist in 2025 BioInnovation Institute & Science Prize for Innovation July 2025 Read More Interview with Dounia Abbadi. Dounia has spent her career investigating a part of the body we use every single day: our muscles. April 2025 Read More mRNA binding proteins join the longevity pipeline: Rebuilding muscle through the power of mRNA binding protein therapeutics April 2025 Read More AUF1 gene transfer increases exercise performance and improves s … re about Regerna, or to receive a copy of our Introductory Presentation, kindly submit an inquiry through this page. Interested in investing? Submit an inquiry on this page to receive our Investor Deck.